The contractor shall provide support for essential activities that are to be performed on a regular basis. This includes: 1) project management; 2) quality assurance/quality control; 3) data…
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,467,826
Award facts
- Contract value 82% obligated
-
- $1,467,826.00 Current, with exercised options
- $1,796,158.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $500,969 | |
| Funding Only Action | $148,483 | |
| Original award | $818,374 |
About this award
The prime contractor, Advanced Bioscience Laboratories, Inc., has been awarded a cost plus fixed fee contract valued at $1.8 million by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under this contract, Advanced Bioscience Laboratories, Inc. will provide preclinical development support services including project management, quality assurance/quality control, data management, storage and shipping, and personnel and physical resources from its place of performance in Potomac, Maryland over a two year period starting in June 2022 through June 2024. No information was provided regarding the use of any subcontractors.
Description
The contractor shall provide support for essential activities that are to be performed on a regular basis. This includes: 1) project management; 2) quality assurance/quality control; 3) data management; 4) storage and shipping; 5) personnel and phys
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 10, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $1,467,826 on 75N93022F00002. Its potential value, with all options, is $1,796,158.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award